HUTCHMED (China) Limited ( HMDCF) - Key Metrics
HMDCF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.16 | $0.01 | $0.01 | $0 |
| 2026Q1 | $0.16 | $0.01 | $0.01 | $0 |
| 2025Q4 | $0.01 | $0 | $0 | $0 |
| 2025Q3 | $0.01 | $0 | $0 | $0 |
| 2025Q2 | $0.16 | $0.26 | -$0.04 | -$0.05 |
HMDCF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 58.70 |
| 2026Q1 | 0% | 76.63 |
| 2025Q4 | 0% | 831.82 |
| 2025Q3 | 0% | 831.82 |
| 2025Q2 | 0% | 2.96 |
HMDCF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.18% | 0% |
| 2026Q1 | 0.14% | 0% |
| 2025Q4 | 0.00% | 0% |
| 2025Q3 | 0.00% | 0% |
| 2025Q2 | -1.47% | 0% |
HMDCF
Price: $2.16
52 week price:
Earnings Per Share: 0.02 USD
P/E Ratio: 108
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 1.9 billion